June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Surgical Outcomes including Visual Improvement in Neovascular Glaucoma after Glaucoma Surgery
Author Affiliations & Notes
  • Ji Hyoung Chey
    Ophthalmology, Ulsan University Hospital, Ulsan, Korea (the Republic of)
  • Hyun Chul Youn
    Ophthalmology, Ulsan University Hospital, Ulsan, Korea (the Republic of)
  • Chang Kyu Lee
    Ophthalmology, Ulsan University Hospital, Ulsan, Korea (the Republic of)
    Biomedical Research Center, Ulsan University Hospital, Ulsan, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Ji Hyoung Chey None; Hyun Chul Youn None; Chang Kyu Lee None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4263. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ji Hyoung Chey, Hyun Chul Youn, Chang Kyu Lee; Surgical Outcomes including Visual Improvement in Neovascular Glaucoma after Glaucoma Surgery. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4263.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Neovascular glaucoma (NVG) is considered refractory glaucoma, but visual outcomes after glaucoma surgery may vary due to the unique etiology and sudden increase in intraocular pressure (IOP). This study investigated the factors related to surgical outcomes, including visual acuity (VA) improvement after glaucoma surgery in eyes with NVG.

Methods : This was a retrospective observational study, and 116 eyes of 116 patients with NVG who underwent trabeculectomy (TLE) or Ahmed glaucoma valve (AGV) implantation performed by a single surgeon in Ulsan national university were included. Complete surgical success at 6 months was defined as improved VA and sufficient IOP reduction (IOP ≤21 mmHg, ≥20% IOP reduction, regardless of medications) without additional glaucoma surgery and progression to NLP or hypotony (IOP ≤5 mmHg at last 2 consecutive visits). Qualified surgical success at 6 months was defined as complete success, excluding improved VA. Preoperative characteristics were investigated, including best-corrected VA (BCVA), IOP, medications, angle status, and underlying retinal etiologies. Postoperative outcomes were measured up to 6 months to avoid visual deterioration caused by the progression of underlying retinal diseases.

Results : Complete surgical success rate was 44.6 %, and the qualified surgical success rate was 92.2 % at 6 months. Comparison between complete and without complete surgical success showed that younger age (p < 0.001), better preoperative BCVA (p = 0.028), a shorter period of decreased VA before surgery (p = 0.014), closed angle status (p = 0.017), underlying etiology in favor of proliferative diabetic retinopathy (p = 0.042), and better postoperative BCVA at 1 month (p < 0.001) were associated with complete surgical success.

Conclusions : Patients with NVG who had younger age, proliferative diabetic retinopathy as an underlying etiology, and complete angle closure had a greater chance of sufficient IOP reduction and improved VA after glaucoma surgery.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×